Baiying Bio offers economic recombinant protein and antibody reagents and is a CRO vendor for life science researchers and biopharma companies. They provide services including HTP recombinant antibody and VHH production, bispecific antibody production, antibody humanization, VHH library generation, hybridoma sequencing, protein expression in mammalian cells, large-scale antibody production, and more. They delivered tens of thousands of recombinant antibodies to customers.
MobiDrop develops microfluidic technologies for life sciences and precision medicine. MobiDrop creates cutting-edge instruments, extensive assays, and simple software for ddPCR and single-cell multi-omic platforms. MobiDrop offers ground-breaking solutions for life science research and IVD.
ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on internally developed, innovative, and proprietary technology platforms, ProfoundBio has developed a pipeline consisting of multiple antibody-drug conjugate (ADC) drug candidates targeting solid tumors and hematological malignancies that are in discovery, preclinical, and clinical development stages.
Starna Therapeutics offers development of innovative drugs with RNA as the core, and has an industry-leading RNA and organ-selective delivery technology platform with independent intellectual property rights; the company has established a rich R&D pipeline , covering infectious disease vaccines, tumor immunity and other fields.
Aspen Neuroscience is a development stage and private biotechnology company that uses innovative genomic approaches combined with stem cell biology to deliver patient-specific, restorative cell therapies that modify the course of Parkinson's disease. It is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical needs, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson's disease (PD) and extending across the brain and affected organs.
Boyue Bio focuses on the development of biomedical raw materials and integrated solutions. The company's four product lines include Bioactive Materials, Nanometer Microspheres, Chromatographic Products, and Integrated Solutions. Boyue Bio seeks to be a major provider of total solutions and core raw materials for the biomedical industry.
SUSTAO is a manufacturer of consumables that meet the technical requirements of medical robots.
Elixir Clinical Research is a technology-based full-featured clinical CRO.
Shenji Bio focuses on the research and development of fundamental raw materials such as nucleosides, nucleotides, diagnostic antigens, and antibodies. As a development direction, Shenji Bio provides cost-effective products and addresses clinical unmet needs. It has gradually entered the upstream core raw material fields of IVD, mRNA, CGT, and other industries, and has established a high-quality key common technology platform to provide overall solutions for the life science field's development.
CellOrigin Biotech is a company committed to iPSC-derived innate immune cell therapeutics.
Molecular Assemblies is a San Diego-based company developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology and more. Inspired by nature, the company’s proprietary DNA synthesis method is designed to produce long, high quality, sequence-specific DNA reliably, affordably and sustainably. With a highly experienced executive and scientific team and an expansive intellectual property portfolio, Molecular Assemblies has attracted investments from Agilent Technologies, Cavendish Impact Capital Fund, Data Collective Venture Capital, Eleven Two Capital, Genomics Investment Syndicate, Keshif Ventures, Newport Holdings, LP, and Alexandria Venture Investments.
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.
Genepoint Biological Technology is an innovative technology that focuses on the initiatives, technology application, and process control of cryogenic biomaterials, which includes the generation of a cryogenic cell storage automation system and the total solution of alternative energy options. They are dedicated to advancing IoT, automation, and intelligence technology and investigating novel cryogenic biomaterial system operating paradigms. They provide the following products: Hatch TM, Pelican, Hatch-Lite, Flexible Robot for Biobank, and Kiosk.
KYVERNA is pioneering a new class of treatments and potential cures for serious autoimmune diseases. The company's therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases.
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
Edge Medical Robotics, Inc. was founded in Longgang, Shenzhen, China on May 4, 2017. It is committed to researching and promoting most advanced smart equipment in the world，polishing the ultimate product with the spirit of pursuing excellence and fineness, improving surgical safety and treatment efficacy, and contributing to uprising the level of social health.
Sciwind Biosciences is a developers of drugs intended to treat metabolic disorders. The company's drugs contain protein and peptide candidates for non-alcoholic steatohepatitis, enabling physicians to treat their patients in an enhanced way.
MingMed is a Chinese company with global competitiveness in independent drug research and development. The company's main product pipeline includes, among other things, ophthalmic drugs, recombinant protein botulinum toxin, tumor immune drugs, and pet immune drugs, as well as a number of potential First-in-Class innovative drugs that have reached the clinical stage.
HC Scientific (Chengdu) L.L.C., established in early 2016, holds the mission of "Empowering Life Sciences, Achieving Excellence with Simplicity." We are dedicated to the development of intelligent solutions in the field of life technology, aspiring to be the most trusted partner for global life science clients. Committed to autonomous research and development of intellectual property, our company is a national high-tech enterprise encompassing equipment R&D, production, and market promotion. We are recognized as a key player in China's "Double Hundred Projects" for new economy development and have been designated by the Ministry of Human Resources and Social Security as an enterprise led by promising overseas returnees. Our company is actively involved in several national and provincial-level significant scientific and technological initiatives. With a team of distinguished experts, professors, and returning PhDs from the international arena, we've accomplished the development of intelligent life science technology platforms. Our product pipeline spans in vitro diagnostics, modern agriculture, scientific research, and more, significantly streamlining the complex tasks for practitioners in the life science field and creating substantial value for each of our collaborative partners.
ProfoundBio is a clinical-stage biotechnology company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer. Built on internally developed, innovative, and proprietary technology platforms, ProfoundBio has developed a pipeline consisting of multiple antibody-drug conjugate (ADC) drug candidates targeting solid tumors and hematological malignancies that are in discovery, preclinical, and clinical development stages.
NeoX Biotech is a biotechnology company combining AI with biophysics to advance drug research and development. NeoX Biotech is dedicated to the discovery and development of macromolecular and multispecific drugs, particularly in the field of immuno-oncology. NeoX Biotech develops a platform for early therapeutic discovery by characterizing protein-protein interactions.
Jianjia Robot develops a hard tissue surgical robot platform promoting technological progress in the field of surgery at home and abroad. Jianjia Robot's orthopedic joint surgical robot, ARTHROBOT, can cover both hip and knee joints, breaking the long-term monopoly of imported surgical robots in this field.
Zhenyi Yiliao
Series A in 2021
Zhenyi Yiliao is a medical enterprise focusing on structural heart disease.
Just Medical is an artificial orthopedic implant device and system developer. Just Medical provides hip knee and average staircase therapy for all surgical product solutions. Just Medical is committed to providing medical products and services that are safe and effective. It maintains high-speed development, and excellence, and gradually improves the product system in order to help doctors and end the patient's pain.
Molecular Assemblies is a San Diego-based company developing a revolutionary, enzymatic DNA synthesis technology capable of powering new products in industrial synthetic biology, personalized therapeutics, precision diagnostics, and eventually information storage, nanotechnology and more. Inspired by nature, the company’s proprietary DNA synthesis method is designed to produce long, high quality, sequence-specific DNA reliably, affordably and sustainably. With a highly experienced executive and scientific team and an expansive intellectual property portfolio, Molecular Assemblies has attracted investments from Agilent Technologies, Cavendish Impact Capital Fund, Data Collective Venture Capital, Eleven Two Capital, Genomics Investment Syndicate, Keshif Ventures, Newport Holdings, LP, and Alexandria Venture Investments.
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.
Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests. Its sensitive and specific tests are based on identification of subtle changes in methylation patterns. Nucleix offers a urine test for monitoring of bladder cancer called Bladder EpiCheck and a blood test for early detection of lung cancer called Lung EpiCheck. Adam Wasserstrom, Danny Frumkin, and Elon Ganor founded it in 2008, with its headquarters in Rehovot in Israel.
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells.
ABclonal Technology is a rapidly growing life science research and diagnostic reagents provider. With scientists from world-class universities, the company thrives on improving the quality of life science research by providing high-quality antibodies, proteins, ELISA kits, NGS library preparation kits and molecular enzymes.
Sciwind Biosciences is a developers of drugs intended to treat metabolic disorders. The company's drugs contain protein and peptide candidates for non-alcoholic steatohepatitis, enabling physicians to treat their patients in an enhanced way.
Cleveland Diagnostics is a commercial-stage diagnostics company developing efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to improve cancer diagnostics. Its solvent interaction analysis technology investigates protein biomarkers at the structural level, providing better and more direct insights regarding the protein origin on the cellular level, thus improving test specificity to the underlying disease process. Its portfolio of non-invasive cancer diagnostics will be expanding from prostate cancer to breast cancer and lung cancer, and certain neurological diseases.
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.
Edge Medical Robotics, Inc. was founded in Longgang, Shenzhen, China on May 4, 2017. It is committed to researching and promoting most advanced smart equipment in the world，polishing the ultimate product with the spirit of pursuing excellence and fineness, improving surgical safety and treatment efficacy, and contributing to uprising the level of social health.
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare products for serious and critical medical conditions in China and North Asia (Korea and Taiwan). CANbridge develops partnerships with Western bio-pharmaceutical companies with clinical-stage pharmaceutical, medical device or diagnostic products that are either unavailable in China/North Asia or address medical needs that are underserved in the region. CANbridge also licenses or obtains exclusive rights to commercialize drug and device products that are approved in their home markets for commercialization in China and North Asia.
Cytek Biosciences is a manufacturer and supplier of flow cytometry products and services.
ImmuneOnco Biopharma, founded in June of 2015 in Zhangjiang High-Tech Park of Shanghai, China, is an early stage biopharmaceutical company dedicated to the development and commercialization of novel cancer immunotherapy products designed to reverse cancer cell-induced immune inhibition and to actively eradicate cancer cells.
Shenqi Medical focuses on the research and manufacture of innovative medical devices. Shenqi Medical offers a comprehensive product portfolio providing solutions for cardiovascular, structural heart disease, and peripheral and neurovascular medical devices in China.
Zhenge Biotech is a macromolecular pharmaceutical contract development and manufacturing organisation.
Just Medical is an artificial orthopedic implant device and system developer. Just Medical provides hip knee and average staircase therapy for all surgical product solutions. Just Medical is committed to providing medical products and services that are safe and effective. It maintains high-speed development, and excellence, and gradually improves the product system in order to help doctors and end the patient's pain.
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.
Burning Rock focuses on providing individualized cancer treatment guidance for the patients. Using medical and bio informatics plus Next-Generation Sequencing (NGS) as the core technologies, the company is committed to offering one-stop solution for clinical and R&D services concerning the genetic testing of individualized cancer treatment. Established in March 2014, Burning Rock is headquartered in Beijing. Its first medical laboratory, "Guangzhou Burning Rock Medical Examination Institute Co., Ltd." is situated on Guangzhou International Bio Island which is blessed with a picturesque environment and rich in scientific research deposits. Later it established a R&D center in Shanghai. It occupies over 10,000 ㎡ in total. Burning Rock is committed to guiding the individualistic treatment of tumor patients, centered around NGS and biomedical informatics, with conventional tumor molecular pathology detection as the cornerstone, trying to build one-stop solutions for individualistic treatment clinical detection service and scientific research of tumor.
AOHUA is a global providers of endoscopy devices and solutions. It is on a mission to take the lead of endoscope technology innovation and push forward the technological progress of endoscopic diagnosis and treatment technology. AOHUA was founded in 1994 and is based in Shanghai, China.
HiFiBiO is a biotherapeutics company that mobilizes the human immune system to combat disease. It commercializes proprietary single-cell technologies for applications in drug and biomarker discovery and development. It also aspires to benefit patients through open-innovation partnerships with industry and academia. HiFiBiO integrates deep-rooted biological expertise with its comprehensive single-cell profiling technologies to discover and accelerate a pipeline of antibody drugs to treat cancer and autoimmune disorders. The company was founded in 2013 and is headquartered in Paris, Ille-de-France.
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of unique host-directed anti-viral. The company is committed to developing safe and effective immuno-biologic therapies to treat the most vulnerable patients. Its founders were ingenious virologists and molecular biologists who realized that targeting a virus is difficult due to the virus’s ability to mutate and avoid the treatment. This ability to mutate also enables the virus to evade vaccines. So instead of trying to hit a moving target, they developed an innovative new approach to fight respiratory viruses: they targeted the host instead of the virus. The company was founded in 2003 and is headquartered in San Diego, California.
Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States.
Baixing Pingan Yaofang is an online pharmacy. They serve vitamin C, vitamin AD, zinc, calcium, carbonate, vitamin AD, cod liver oil, calcium complex multi-vitamins, complex minerals, and kidney nourishes the kidneys and the liver, and gelatin contains folic acid.
Provider of integrated oral medical solutions for oral health and dental industry. The company offers technical training, operation and management consulting services to their clients. The company also involves in the design, development, manufacturing, and sales of oral medical equipment, providing a full fledged ecosystem for the dental and oral health industry.
Burning Rock focuses on providing individualized cancer treatment guidance for the patients. Using medical and bio informatics plus Next-Generation Sequencing (NGS) as the core technologies, the company is committed to offering one-stop solution for clinical and R&D services concerning the genetic testing of individualized cancer treatment. Established in March 2014, Burning Rock is headquartered in Beijing. Its first medical laboratory, "Guangzhou Burning Rock Medical Examination Institute Co., Ltd." is situated on Guangzhou International Bio Island which is blessed with a picturesque environment and rich in scientific research deposits. Later it established a R&D center in Shanghai. It occupies over 10,000 ㎡ in total. Burning Rock is committed to guiding the individualistic treatment of tumor patients, centered around NGS and biomedical informatics, with conventional tumor molecular pathology detection as the cornerstone, trying to build one-stop solutions for individualistic treatment clinical detection service and scientific research of tumor.
Burning Rock focuses on providing individualized cancer treatment guidance for the patients. Using medical and bio informatics plus Next-Generation Sequencing (NGS) as the core technologies, the company is committed to offering one-stop solution for clinical and R&D services concerning the genetic testing of individualized cancer treatment. Established in March 2014, Burning Rock is headquartered in Beijing. Its first medical laboratory, "Guangzhou Burning Rock Medical Examination Institute Co., Ltd." is situated on Guangzhou International Bio Island which is blessed with a picturesque environment and rich in scientific research deposits. Later it established a R&D center in Shanghai. It occupies over 10,000 ㎡ in total. Burning Rock is committed to guiding the individualistic treatment of tumor patients, centered around NGS and biomedical informatics, with conventional tumor molecular pathology detection as the cornerstone, trying to build one-stop solutions for individualistic treatment clinical detection service and scientific research of tumor.
Fuzhou Kangwei Network Technology is a management platform for blood glucose disease monitoring. They offer a data engine to provide decision support for doctors' diagnoses and treatments. Their data engine recommends diagnosis and treatment suggestions based on the patient's blood glucose data, and doctors can formulate diagnosis and treatment plans professionally and quickly according to the patient's condition.
WinnTi Medical creates medical devices through continuous product innovations and manufacturing improvements, meeting surgeons' increasing demands, and improving patients' wellness.